Semaglutide addresses two critical areas of metabolic health, making it a highly effective treatment for type 2 diabetes and medical weight loss. It enhances insulin regulation by increasing insulin secretion in response to meals while suppressing the release of glucagon, a hormone that raises blood sugar. This dual mechanism ensures better stabilization of blood sugar levels. 

Additionally, Semaglutide suppresses appetite by slowing gastric emptying, which keeps food in the stomach longer, reducing hunger and calorie intake. Clinical trials, such as the STEP trials, have demonstrated that Semaglutide can help patients lose an average of 12-15% of their body weight, making it one of the most effective medications available for weight management.